Shares of Tandem Diabetes Care (TNDM) rose on Thursday as Truist upgraded the insulin pump maker to Buy from Hold, becoming the latest brokerage to raise its rating based on the company’s new ...

Tandem Diabetes (TNDM) stock jumps as Piper Sandler upgrades the company arguing that its pay-as-you-go pharmacy model could ...

Tandem Diabetes Care, Inc. TNDM shares ended the last trading session 9.1% higher at $23.91. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

The past six months have been a windfall for Tandem Diabetes’s shareholders. The company’s stock price has jumped 93.6%, hitting $24.34 per share. This was partly due to its solid quarterly results, ...

In March 2026, Tandem Diabetes Care announced that its Tandem Mobi automated insulin delivery system can now be controlled via the Tandem Mobi mobile app on compatible Android smartphones in the U.S., ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable ...

Tandem Diabetes Care's Tandem Mobi insulin delivery system app is now available to Android users in the U.S. The update expands access to the company’s automated insulin delivery technology beyond iOS ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor ...

– Enhanced features extend automated insulin delivery (AID) to people ages 2 years and older with type 1 diabetes and adults with type 2 diabetes – Control-IQ+ automated insulin delivery technology ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine ...